CTOs on the Move

Terns Pharmaceuticals

www.ternspharma.com

 
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.ternspharma.com
  • 1065 East Hillsdale Boulevard Suite 100
    Foster City, CA USA 94404
  • Phone: 650.275.4395

Executives

Name Title Contact Details

Funding

Terns Pharmaceuticals raised $30M on 04/03/2018
Terns Pharmaceuticals raised $80M on 10/30/2018
Terns Pharmaceuticals raised $87M on 01/05/2021

Similar Companies

Pharmascience

Leader in the manufacture of generic drugs, we produce and distribute brand name drugs and over-the-counter drugs. Based in Montreal, Canada, we have about 1 500 employees. Our products are sold in more than sixty countries. Our portfolio of 340 products cumulates 2000 different dosage strengths. We invest $ 30 million per year in research and development. We firmly believe that we must be an example in our community. We support many charities, here as elsewhere. For international humanitarian purposes, we have donated products valued at approximately $ 23.5 million over the past five years.

Bioxel Pharma

Valley Oaks Health

Amring Pharmaceuticals

Amring promotes health across communities by providing reliable, safe, and affordable medications bringing value to patients and improving quality of life.

Blue Mountain Quality Resources Inc

Blue Mountain Quality Resources Inc is a State College, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.